---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-041721"
form_type: "8-K"
ticker: "BIAF"
cik: "0001712762"
company_name: "bioAffinity Technologies, Inc."
filed_at: "2024-10-21T23:59:59+00:00"
generated_at: "2026-05-30T12:22:24.541696+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# bioAffinity prices $2.66M registered direct offering and concurrent private placement of common stock and warrants

## Summary
- Offering includes 2,048,294 shares at $1.30 per share and warrants to buy up to 2,662,782 shares at $1.50.
- Gross proceeds expected ~$2.66M; closing on or about Oct. 21, 2024; WallachBeth Capital acting as placement agent (8% fee).
- Warrants exercisable upon stockholder approval and expire in five years; officers/directors subject to 60-day lock-up.
- Bylaws amended to set quorum at 34% of outstanding shares entitled to vote, effective Oct. 17, 2024.
- Shares offered under effective S-3 shelf; warrants issued in private placement exempt from registration.

## SEC filing metadata
- accession: 0001493152-24-041721
- form_type: 8-K
- ticker: BIAF
- cik: 0001712762
- company_name: bioAffinity Technologies, Inc.
- filed_at: 2024-10-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1712762/000149315224041721/0001493152-24-041721-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1712762/000149315224041721/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-041721
- JSON: https://secwatch.observer/filing/0001493152-24-041721.json
- Plain text: https://secwatch.observer/filing/0001493152-24-041721.txt

## Key facts
- Governance Changes
  bioAffinity Technologies, Inc.: Amended quorum requirement to 34% of outstanding shares entitled to vote (effective 2024-10-17).
  - Change: bylaw amendment
  - Effective: 2024-10-17
  source text: On October 17, 2024, the Board amended the Company’s Amended and Restated By-Laws, effective October 17, 2024, in order to amend the quorum requirement of Article II, Section 2.07 of the Amended and Restated By-Laws, such that thirty-four percent (34%) of the outstanding shares of stock of the Company entitled to vote at the meeting, present in person or represented by proxy, shall constitute a quorum for the transaction of business at all meetings of the stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1712762/000149315224041721/0001493152-24-041721-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.